Coagulatory Defects in Type-1 and Type-2 Diabetes

被引：55
|
作者：
Sobczak, Amelie I. S. [1 ]
Stewart, Alan J. [1 ]
机构：
[1] Univ St Andrews, Sch Med, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2019年 / 20卷 / 24期
关键词：
atherosclerosis; endothelial dysfunction; magnesium; metal ions; microparticles; platelets; thrombosis; zinc; CHOLESTEROL EFFLUX CAPACITY; CORONARY-HEART-DISEASE; TISSUE FACTOR PATHWAY; ACTIVATABLE FIBRINOLYSIS INHIBITOR; ERYTHROCYTE-DERIVED MICROPARTICLES; DENSITY-LIPOPROTEIN FUNCTION; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GLYCEMIC CONTROL; THROMBIN GENERATION;
D O I：
10.3390/ijms20246345
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coagulatory microparticles and endothelial dysfunction. In this review, we explore the different mechanisms by which diabetes leads to an increased risk of developing coagulatory disorders and how this differs between type-1 and type-2 diabetes.
引用
收藏
页数：27
相关论文
共 50 条
  • [31] STRUCTURE AND FUNCTION OF THE CORNEAL ENDOTHELIUM IN DIABETES-MELLITUS TYPE-1 AND TYPE-2
    LARSSON, LI
    BOURNE, WM
    PACH, JM
    BRUBAKER, RF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S300 - S300
  • [32] Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
    Przyklenk, Karin
    Maynard, Michelle
    Greiner, Dale L.
    Whittaker, Peter
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (05) : 781 - U384
  • [33] EXERCISE IS NOT ASSOCIATED WITH BETTER DIABETES CONTROL IN TYPE-1 AND TYPE-2 DIABETIC SUBJECTS
    SELAM, JL
    CASASSUS, P
    BRUZZO, F
    LEROY, C
    SLAMA, G
    ACTA DIABETOLOGICA, 1992, 29 (01) : 11 - 13
  • [34] CHARACTERIZATION OF THE CHLORPROPAMIDE-ALCOHOL-FLUSH IN PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES
    PONTIROLI, AE
    DEPASQUA, A
    COLOMBO, R
    RICORDI, C
    POZZA, G
    ACTA DIABETOLOGICA LATINA, 1983, 20 (02): : 117 - 123
  • [35] Differential impact of type-1 and type-2 diabetes on control of heart rate in mice
    Stables, Catherine L.
    Auerbach, David S.
    Whitesall, Steven E.
    D'Alecy, Louis G.
    Feldman, Eva L.
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2016, 194 : 17 - 25
  • [36] INTESTINAL TRANSIT DISORDERS IN PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES-MELLITUS
    FOLWACZNY, C
    KUHN, M
    VOLGER, C
    SORODOC, J
    HUNDEGGER, K
    TATSCH, K
    LANDGRAF, R
    KARBACH, U
    GASTROENTEROLOGY, 1995, 108 (04) : A599 - A599
  • [37] Postconditioning fails to limit infarct size in the setting of type-2 and type-1 diabetes
    Przyklenk, Karin
    Maynard, Michelle
    Smith, Craig S.
    Whittaker, Peter
    CIRCULATION, 2007, 116 (16) : 97 - 97
  • [38] Regeneration and healing of bone and cartilage in type-1 and type-2 diabetes: the effects of insulin
    Akyol, Sumeyya
    Gulec, Mehmet Akif
    Demirin, Hilmi
    Akyol, Omer
    TURKISH JOURNAL OF BIOLOGY, 2016, 40 (02) : 327 - 332
  • [39] Health economic evaluation of insulin glargine for the treatment of type-1 and type-2 diabetes
    Thompson, M
    Sauriol, L
    Grima, D
    VALUE IN HEALTH, 2005, 8 (06) : A163 - A163
  • [40] Type-1 and Interval Type-2 ANFIS: A Comparison
    Chen, Chao
    John, Robert
    Twycross, Jamie
    Garibaldi, Jonathan M.
    2017 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE), 2017,
12345